Vimarsana
Biggest News Aggregation in the World

Stacy Roughan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stacy Roughan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stacy Roughan Today - Breaking & Trending Today

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference - Vimarsana News

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX--Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease therapeutics, today announced that Dirk Thye, M.D., Quince’s Chief Executi...

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor - Vimarsana News

Quince Therapeutics Engages MTS Health Partners as Independent Financial Advisor

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX--Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that it has retained MTS Health Partners, L.P. (MTS) as its financial ad...

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan - Vimarsana News

Quince Therapeutics Adopts Limited Duration Stockholders Rights Plan

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--$QNCX--Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics that transform patients’ lives, today announced that its Board of Directors (the “Board”) unanimously approved the adopt...

Cortexyme Appoints June Bray to its Board of Directors - Vimarsana News

Cortexyme Appoints June Bray to its Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on rare and degenerative diseases, today announced the appointment of June Bray, a pharmaceutical industry veteran and global drug development and regulatory process expert, to the company...